Eubelius assists ViroVet on its succesful Series C financing round

News
24 June 2022
Corporate and M&A

Congratulations to ViroVet on its successful Series C financing round. Since the company was founded, almost EUR 20,000,000 of capital has been raised.

ViroVet is active in the development of breakthrough and innovative technologies for the control and treatment of viral diseases in livestock.

We are proud to have assisted ViroVet with this transaction.

The Eubelius team involved in the transaction consisted of Matthias Wauters, Fréderic Van Campe and Odile Watté.

Matthias

Matthias Wauters

Partner

Fréderic Van Campe

Counsel

Odile Watté

Attorney

Eubelius assists The Organic Consumer Group with the acquisition of La Saponaria

Eubelius assisted The Organic Consumer Group (a Damier company) with its acquisition of La Saponaria, an Italian producer and distributor of...

Practices that M&A dealmakers should avoid: European courts clarify the concept of “gun jumping”

The Court of Justice of the EU (“CJEU”) has clarified which pre-closing veto rights and conduct should be avoided by parties to an M&A...

Changes in accounting treatment for new merger and demerger operations

The Royal Decree of 26 November 2023 regulates the accounting treatment of the new operations assimilated to mergers and demergers made...